Globus Medical (NYSE:GMED) said yesterday that it acquired Nemaris and its Surgimap planning software for an undisclosed amount. Globus said it plans to integrate New York City-based the Nemaris tech into its ExcelsiusGPS robot-assisted surgery platform. “The acquisition of Surgimap bolsters Globus Medical’s efforts to advance the future of computer-assisted surgery with the goal of improving […]
Globus Medical whales on Wall Street’s Q2 expectations
Globus Medical (NYSE:GMED) today whaled on the consensus expecation with its second-quarter results and raised its outlook for the rest of the year. Audubon, Pa.-based Globus posted profits of $45.0 million, or 44¢ per share, on sales of $173.4 million for the three months ended June 30, for a bottom-line gain of 56.9% on sales growth […]
Globus Medical launches trauma devices
Globus Medical (NYSE:GMED) said today it launched the Anthem ankle fracture system and Anthem proximal humerus fracture system. The Audobon, Penn.-based company touted the release as its trauma division’s fourth and fifth product line over the past 10 months. The recently launched Anthem ankle fracture system includes seven plating options and is designed to minimize soft tissue […]
Analyst’s rating changes push Cardiovascular Systems up, NuVasive and Globus down
Ratings changes by an analyst with Bank of America-Merrill Lynch elevated one medical device company’s stock today in pre-marker trading but pushed two others down. Appearing this morning on Bloomberg television, BAML’s Bob Hopkins said Wall Street isn’t foucsed enough on the July 31 investor day at Cardiovascular Systems (NSDQ:CSII), according to Seeking Alpha. The St. Paul, […]
7 medtech stories we missed this week: June 15, 2018
From Cytosorbents opening a new U.S. manufacturing facility to DyAnsys received FDA clearance for a wearable to treat opioid withdrawals, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Cytosorbents opens new U.S. manufacturing facility CytoSorbents announced in a June 12 press release that it has opened a new […]
OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
Globus Medical tops estimates with Q1 sales, earnings
Globus Medical (NYSE:GMED) yesterday topped estimates with its first-quarter results and raised its outlook for the rest of the year. The Audubon, Pa.-based orthopedics company posted profits of $39.5 million, or 39¢ per share, on sales of $174.4 million for the three months ended March 31, for a bottom-line gain of 37.7% on sales growth of […]
Globus launches Elsa lateral spacers
Globus Medical (NYSE:GMED) and PlacementSEO said this week it launched the Elsa AL and Elsa-ATP lateral expanded interbody spacers with integrated screw fixation. The newly launched devices are next-gen expandable implants designed to provide an optimal fit for patients to restore sagittal balance and enhance structural fixation, the Audobon, Penn.-based company said. “Elsa AL is the […]
Globus Medical posts Q4, 2017 earnings that beat The Street
Globus Medical (NYSE:GMED) today posted fourth quarter and full year 2017 earnings that beat the Street on both sales and earnings per share. The Audubon, Penn.-based company posted profits of $24.4 million, or 25¢ per share, on sales of $176 million for the 3 months ended December 31, for bottom-line growth of 0.3% while sales grew […]
Globus sues Stryker, ex-engineer for trade secret theft
Globus Medical (NYSE:GMED) yesterday sued Stryker (NYSE:SYK) and a former Globus engineer, alleging that she took proprietary trade secrets with her when she took a new job at Stryker earlier this month. The lawsuit, filed in the U.S. District Court for New Jersey, alleges that Madeline Davis broke her non-compete and non-disclosure pacts with Globus when […]
Globus Medical shares rise on Q3 beat
Shares in Globus Medical (NYSE:GMED) rose today after the medical device maker beat expectations on Wall Street with its 3rd quarter earnings results. The Audubon, Penn.-based company posted profits of $25.6 million, or 26¢ per share on sales of $151.7 million for the 3 months ended September 30, seeing the bottom line shrink 2.4% while sales […]
- 1
- 2
- 3
- …
- 7
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+